Literature DB >> 2778653

Comparative pharmacokinetics of coumarin anticoagulants. XLIX: Nonlinear tissue distribution of S-warfarin in rats.

W K Cheung1, G Levy.   

Abstract

The serum protein binding of the oral anticoagulant drug warfarin varies widely among rats and largely accounts for corresponding variations in the total serum clearance of the drug. The hepatic uptake of warfarin is concentration dependent despite the concentration independence of the free fraction of warfarin in serum over a wide concentration range. This investigation was designed to determine the distribution of the S enantiomer of warfarin in rats as a function of warfarin concentration, free fraction in serum, dose, and time. Two groups of rats, one with relatively low (0.0043) and the other with relatively high (0.0105) average serum free fraction values, were selected from a large number of adult male Sprague-Dawley rats. All animals received an iv injection of S-warfarin, either 0.25 or 1.0 mg/kg, and were sacrificed at intervals over a period of 10 d. Concentrations of S-warfarin in serum, liver, kidneys, muscle, and fat were determined by HPLC. The tissue:serum concentration ratio (T:S) of the drug was highly concentration dependent, but was independent of dose, time, and (except for fat) free fraction in serum. The T:S for fat was higher in animals with the larger serum free fraction values. The T:S of S-warfarin for the liver was greater than 10 at low concentrations and reached a limiting value of 0.25 at relatively high concentrations of the drug. In general, the T:S versus concentration profiles of S-warfarin are consistent with the presence of two classes of binding sites in the tissues, one with very high affinity and low capacity, the other with lower affinity and apparently unlimited capacity under the experimental conditions.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2778653     DOI: 10.1002/jps.2600780706

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

1.  A combined specific target site binding and pharmacokinetic model to explore the non-linear disposition of draflazine.

Authors:  E Snoeck; P Jacqmin; A Van Peer; M Danhof
Journal:  J Pharmacokinet Biopharm       Date:  1999-06

2.  Population pharmacokinetic modelling of S-warfarin to evaluate the design of drug-drug interaction studies for CYP2C9.

Authors:  Kerenaftali Klein; Ivelina Gueorguieva; Leon Aarons
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-01-21       Impact factor: 2.745

3.  Perspectives on the history and scientific contributions of Gerhard Levy.

Authors:  Ho-Leung Fung; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-09-24       Impact factor: 2.745

4.  Target-Mediated Drug Disposition Pharmacokinetic-Pharmacodynamic Model of Bosentan and Endothelin-1.

Authors:  Anke-Katrin Volz; Andreas Krause; Walter Emil Haefeli; Jasper Dingemanse; Thorsten Lehr
Journal:  Clin Pharmacokinet       Date:  2017-12       Impact factor: 6.447

5.  Dose-dependent pharmacokinetics of warfarin in healthy volunteers.

Authors:  S Y King; M A Joslin; K Raudibaugh; H J Pieniaszek; I H Benedek
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

6.  Impact of target interactions on small-molecule drug disposition: an overlooked area.

Authors:  Robert A B van Waterschoot; Neil J Parrott; Andrés Olivares-Morales; Thierry Lavé; Malcolm Rowland; Dennis A Smith
Journal:  Nat Rev Drug Discov       Date:  2018-02-23       Impact factor: 84.694

7.  Disposition of azole antifungal agents. II. Hepatic binding and clearance of dichlorophenyl-bis-triazolylpropanol (DTP) in the rat.

Authors:  H L Bomont; M H Tarbit; M J Humphrey; J B Houston
Journal:  Pharm Res       Date:  1994-07       Impact factor: 4.200

8.  Analysis of tissue distribution of valproate in guinea-pigs: evidence for its capacity-limited tissue distribution.

Authors:  H Y Yu; Y Z Shen
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

9.  Target-Mediated Population Pharmacokinetic Modeling of Endothelin Receptor Antagonists.

Authors:  Anke-Katrin Volz; Jasper Dingemanse; Andreas Krause; Thorsten Lehr
Journal:  Pharm Res       Date:  2019-12-10       Impact factor: 4.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.